Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Granules receives USFDA nod for  Potassium Chloride Extended-Release Tablets USP

      Granules receives USFDA nod for Potassium Chloride Extended-Release Tablets USP

      Medical Dialogues Bureau7 March 2020 10:00 AM IST
      Potassium Chloride ER Tablets are used for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom...
      USFDA accepts regulatory submission for tanezumab for management of chronic pain  due to osteoarthritis

      USFDA accepts regulatory submission for tanezumab for management of chronic pain due to osteoarthritis

      Medical Dialogues Bureau7 March 2020 10:00 AM IST
      Tanezumab is a monoclonal antibody that is part of an investigational class of non-opioid chronic pain medications known as nerve growth factor (NGF)...
      Sanctions-hit Iran struggles to make cancer drugs: Report

      Sanctions-hit Iran struggles to make cancer drugs: Report

      Medical Dialogues Bureau7 March 2020 9:00 AM IST
      Iran: A lab-coated technician leans over a bioreactor at an Iranian pharmaceutical plant producing cancer drugs -- a tall order since equipment...
      Europe panicking over Indias pharmaceutical export curbs - Pharmexcil

      Europe 'panicking' over India's pharmaceutical export curbs - Pharmexcil

      Medical Dialogues Bureau6 March 2020 3:10 PM IST
      The list of restricted medicines accounts for 10% of India's total pharmaceutical exports and includes several antibiotics, as well as Paracetamol, a...
      Worlds first drug for treatment of Non-Cirrhotic NASH approved: Zydus

      World's first drug for treatment of Non-Cirrhotic NASH approved: Zydus

      Medical Dialogues Bureau6 March 2020 2:26 PM IST
      Saroglitazar is uniquely poised with its dual PPAR alpha and gamma properties – reducing the comorbidities (dyslipidemia, hypertriglyceridemia,...
      Lupin Launches Authorized Generic version of Vimovo®  delayed-release tablets

      Lupin Launches Authorized Generic version of Vimovo® delayed-release tablets

      Medical Dialogues Bureau6 March 2020 11:00 AM IST
      The product is a combination of naproxen, a non-steroidal anti-inflammatory drug (NSAID), and esomeprazole magnesium, a proton pump inhibitor (PPI)
      Need to reduce dependency on API imports: Minister appeals to Pharma Companies

      Need to reduce dependency on API imports: Minister appeals to Pharma Companies

      Medical Dialogues Bureau5 March 2020 5:07 PM IST
      Generic medicines sold at dedicated Jan Aushadhi stores are cheaper by at least 50% and for some even by 90%.
      WHO warns of global shortage of medical equipment, surgical masks, protective gowns, gloves to fight coronavirus

      WHO warns of global shortage of medical equipment, surgical masks, protective gowns, gloves to fight coronavirus

      Medical Dialogues Bureau5 March 2020 3:14 PM IST
      Washington: The World Health Organization (WHO) on Tuesday warned of a global shortage and price gouging for protective equipment to fight the...
      IDMA warns of adverse impact of coronavirus on Indian Pharma Companies

      IDMA warns of adverse impact of coronavirus on Indian Pharma Companies

      Medical Dialogues Bureau5 March 2020 1:13 PM IST
      There is no immediate short-term impact of coronavirus but this may change if the epidemic drags on
      India Pharma & India Medical Device 2020 Conference to be held from 5 -7 March at Gandhinagar

      India Pharma & India Medical Device 2020 Conference to be held from 5 -7 March at Gandhinagar

      Medical Dialogues Bureau5 March 2020 12:48 PM IST
      The objective of this event is to promote consumer-centric manufacturing by involving Medical Electronics, Devices, Health Diagnostics, Hospitals and...
      HC relief  to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

      HC relief to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

      Medical Dialogues Bureau5 March 2020 12:45 PM IST
      It also said that prima facie the methodology used by NAPA to arrive at its finding of profiteering was "flawed".
      Valisure Detects High Levels of NDMA in Metformin

      Valisure Detects High Levels of NDMA in Metformin

      Medical Dialogues Bureau5 March 2020 9:00 AM IST
      FDA currently recognizes the danger of this compound and, as a result, has set strict daily acceptable intake limits and advised companies to recall...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok